Menu
Thor Medical ASA will publish its second-half and full-year 2025 results on Thursday, February 26, 2026, at 07:00 CET.
The company will host a presentation of the results at 08:00 CET the same day at Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and media are invited to attend.
Date: Thursday, February 26, 2026
Time: 08:00 CET
Venue: Sjølyst Møtesenter, Drammensveien 165, Oslo
Webcast: https://qcnl.tv/p/oaKSlZtoFMGAjpGTZIKcdg
The interim financial report for the second half and full year of 2025, and presentation material, will be released at 07:00 CET and made available on www.thormedical.com
CONTACTS
Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, Thor Medical ASA, +47 988 05 724, mathias.reierth@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of alpha particle emitters produced from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.com.
